cabotegravir 30 MG Oral Tablet [Vocabria]

RxCUI
2475205
RxNorm name
cabotegravir 30 MG Oral Tablet [Vocabria]
Display name
cabotegravir 30 MG Oral Tablet [Vocabria]
Full name
cabotegravir 30 MG Oral Tablet [Vocabria]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VocabriaCABOTEGRAVIR SODIUMViiV Healthcare Company66d450fb-cca4-476c-b0c7-c0730e3e4cf32025-04-11Warnings, Adverse reactionsExact identifier
rxcui: 2475205

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
66d450fb-cca4-476c-b0c7-c0730e3e4cf3VOCABRIA 30 MG Oral Tablet [PSN] · cabotegravir 30 MG Oral Tablet [Vocabria] [SBD] · Vocabria 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet [SY] · Vocabria 30 MG Oral Tablet [SY]48These highlights do not include all the information needed to use VOCABRIA safely and effectively. See full prescribing information for VOCABRIA. VOCABRIA (cabotegravir) tablets, for oral use Initial U.S. Approval: 202120250411